Navigation Links
Chiltern Enhances Its Portfolio of Electronic Data Capture (EDC) Services With the Addition of Hosting and eCRF Design Services for DataLabs (by ClinPhone) and Medidata Rave(R) Certification
Date:6/22/2008

LONDON, June 23 /PRNewswire/ -- Chiltern, a leading global research organization announced today the integration of DataLabs v4.1.4 into its suite of clinical trial management applications providing sponsors and investigators with enhanced services for the collection and management of electronic clinical trial data. Chiltern has completed installation and validation of the DataLabs EDC system according to 21CRF Part 11 requirements. eCRF hosting services are available (with full server redundancy) at Chiltern locations in Bristol Tennessee (US) and London (UK) and the programming of several eCRFs by Chiltern is currently underway. Chiltern's in-house EDC capabilities now include provision of all eClinical services relating to DataLabs by ClinPhone with resulting efficiency savings for our sponsors.

In April 2008, Chiltern staff have also achieved Medidata Rave(R) certification using Medidata's ASPire to Win Program. As a result and in addition to our well established existing Rave(R) services relating to EDC training and data management, Chiltern now also has the capability to program eCRFs using Rave(R) and collaborates with Medidata for support services such as hosting.

"Chiltern continues to be at the vanguard of EDC technology implementation," said Jim Esinhart, VP Global Biometrics, "and we are pleased to be able to assist our sponsors with our detailed knowledge and experience in clinical trials combined with the flexibility to utilize two of the leading EDC systems in Medidata Rave(R) and ClinPhone EDC. Where our sponsors express a preference for other systems, Chiltern's general EDC experience also allows us to continue to work with other EDC vendors in service areas such as EDC training, data management and monitoring. In particular, Chiltern has a strong track record with PhaseForward's InForm(TM) software."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1,200 people with 23 offices across the Americas, Europe, Latin America and in India. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

For More Information Contact:

Catherine Lemercier

Chiltern International, Inc.

2111 Palomar Airport Road

Suite 200

Carlsbad

CA 92011

USA

Tel: 1 (760) 707 5025

Fax: 1 (760) 707 5022

Email: catherine.lemercier@chiltern.com

Richard Baptista

Chiltern International Ltd.

171 Bath Road

Slough

Berkshire

SL1 4AA

UNITED KINGDOM

Tel: 44 (0) 1753 512 000

Fax: 44 (0) 1753 511 116

Email: richard.baptista@chiltern.com

Chiltern: Understanding


'/>"/>
SOURCE Chiltern
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chiltern Expands Its Global Reach to Latin America
2. Chiltern Announces New Expansion in Portugal
3. Chiltern Opens a New Office in Russia
4. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
5. Chiltern Wins Top Prize
6. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
7. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
8. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
9. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
10. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
11. Marco Romano, MD Joins Chiltern as Medical Director, Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... Month and the focus is on prostate cancer. Second only to skin cancer, prostate ... common cause of cancer related death today; lung cancer remains in the number one spot. ... during his lifetime. Those at highest risk are men who have a family ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ... an alarm system installed. But unless there is a working deadbolt lock that is ... Premier Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived ... loss in these patients. , But how often do ophthalmologists and optometrists in Sweden ... at risk of or with early symptoms of AMD? A study published recently ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant ... Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by long-time ... in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology: